Two new proposed class-action lawsuits filed in federal court this month are seeking damages for health problems residents say they suffered as a result of the 2024 BioLab fire in Conyers.
The filings come just days before the second anniversary of the Sept. 29, 2024, fire that sent a chemical plume across the metro-Atlanta area, prompting the evacuations and leading to overnight shelter-in-place orders that continued for weeks.
The latest lawsuit, Gregg et al. v. Bio-Lab, Inc. et al, was filed Sept. 22 by five Rockdale County residents. The complaint is seeking damages for personal injury and property damage.
A separate proposed class action, Baron et al. v. Bio-Lab, Inc. et al., filed Sept. 16, also alleges residents suffered health problems after the fire. The complaint names 20 adults and two minors who reported respiratory, throat, eye and skin problems, among other health issues.
The Baron complaint draws on findings from the U.S. Chemical Safety Board’s final investigation released in July. CSB federal investigators found that a corroded sprinkler failed, allowing water to come into contact with reactive pool chemicals stored inside the facility and triggering the chemical reaction that led to the fire.
Both lawsuits name BioLab, its parent company KIK Consumer Products and other KIK-related entities as defendants. They also name Centerbridge Partners, the private equity firm that owns KIK as a defendant. The suits detail the history of fires at the Conyers plant.
The plaintiffs in the Baron case are also asking for environmental testing and cleanup, additional air monitoring and other measures aimed at addressing long-term effects of plume.
Both suits are seeking compensation for alleged injuries and economic losses, as well as attorneys’ fees and other costs. They both also ask the court to require the defendants to pay for medical monitoring for residents in affected areas.
An existing consolidated federal class action lawsuit stemming from the fire has largely focused on property and economic damages. Medical monitoring has also remained a central legal question in that litigation.
Neither of the new lawsuits has been yet certified as a class action.
BioLab made products to clean pools and spas until the 2024 fire at its Conyers facility. In May 2025, the company announced it would no longer manufacture at the site. The property was listed for sale January 2026.
GPB has reached out to lawyers for the plaintiffs and BioLab for comment.
For more on the 2024 BioLab fire and GPB’s investigation, listen to Manufacturing Danger: The BioLab Story wherever you get your podcasts. Season 3 debuts Sept. 29.
